drugset / Trial / NCT06160414
A Study to Investigate the Potential Drug Interactions Between ALXN2080 and Rosuvastatin and Metformin in Healthy Adult Participants
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary objectives of this study are to determine the effect of multiple doses of ALXN2080 on the single-dose PK of rosuvastatin and to determine the effect of multiple doses of ALXN2080 on the single-dose PK of metformin.
Timeline
- Start
- 2023-04-12
- Primary completion
- 2024-02-05
- Completion
- 2024-02-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | — | Oral |
| Subject | Rosuvastatin | Small molecule | — | Oral |
| Subject | ZORACOPAN | Small molecule | — | Oral |
Indications
No indication recorded.